The invention relates to recombinant Measles virus expressing Chikungunya virus polypeptides and concerns in particular virus like particles (VLP) that contain envelope and capsid proteins of a Chikungunya virus at their surface. These particles are recombinant infectious particles able to replicate in a host after an administration. The invention provides means in particular nucleic acids, vectors , cells and rescue systems to produce these recombinant infectious particles. The invention also relates to the use of these recombinant infectious particles, in particular under the form of a composition , more particularly in a vaccine formulation for the treatment or prevention of an infection by Chikungunya virus.
